SOURCE: MedLink International, Inc.

May 29, 2007 15:01 ET

Griffen-Rose, LLC Initiates Research Coverage on MedLink

Acquisitions, MedLink TV, and New Software Launch Will Drive Revenue Growth in 2007

NEW YORK, NY--(Marketwire - May 29, 2007) - Griffen-Rose, LLC, an independent New York City-based research firm, announced today that it has inititated research coverage on MedLink International, Inc. (OTCBB: MLKNA) (FRANKFURT: WM6B) ("MedLink"), the electronic health record software company. The entire report can be accessed through the Griffen-Rose website.

About Griffen-Rose, LLC

Griffen-Rose, LLC is an independent New York-based research firm providing objective and rigorous business analysis and research on public and private companies. Griffen-Rose reports are accessible by institutional and individual investors through effective distribution to a significant database of money managers, private equity firms, venture capitalists, hedge funds, investment banks and senior industry executives. Griffen-Rose analysts possess in-depth industry experience and intimate knowledge of the companies they cover and company reports are carried on the top professional financial information channels such as Bloomberg, Factset and Reuters.

About MedLink International, Inc.

MedLink International is a publicly held NASDAQ Bulletin Board and Frankfurt Stock Exchange company (OTCBB: MLKNA) (FRANKFURT: WM6B), which supplies its proprietary MedLink EHR software via a Virtual Private Network (VPN) to a network of physicians, radiology clinics and other types of medical offices.

The MedLink VPN allows subscribing doctors to securely communicate with other physicians and remotely access and retrieve patient records, lab results, X-Rays, CAT Scans and other patient health information. Through its VPN, MedLink offers member institutions and physicians other products and services, such as MedLink TV, MedLink Scheduler, MedLink Billing, Secure Health Mail, Remote PACS, Health IT infrastructure and networking, document management, and video conferencing.

The MedLink VPN delivers pertinent drug information from pharmaceutical companies to physicians. In addition to the physician Virtual Private Network, MedLink is also providing a consumer network displaying medical education, information and advertising on a network of digital screens installed in the waiting rooms of radiology clinics, medical laboratories, and physician offices. Please visit www.medlinkus.com for more information.

FORWARD-LOOKING STATEMENTS

Statements contained in this press release, which are not historical facts, are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based largely on current expectations and are subject to a number of known and unknown risks, uncertainties and other factors beyond our control that could cause actual events and results to differ materially from these statements. These statements are not guarantees of future performance, and readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. MedLink International, Inc. undertakes no obligation to update publicly any forward-looking statements.

Contact Information

  • Contact:
    Griffen Rose LLC
    Attn: Rexford Darko
    67 Wall Street
    22nd Floor
    New York, NY 10005
    (212) 784-6185

    MedLink International, Inc.
    IR@medlinkus.com
    Attn: James Rose
    (631) 342-8800